首页> 外国专利> drugs active against the etiological agent of chronic fatigue syndrome

drugs active against the etiological agent of chronic fatigue syndrome

机译:对抗慢性疲劳综合症病因的药物

摘要

the drugs caparsolate and filaramide, when administered intravenously, in the amount of 0.1 ml / kg of weight of the subject being treated per day for two days.lead to the clinical cure of the disease (chronic fatigue syndrome) identified the following symptoms: anorexia, asthenia, fatigue, weight loss, hyperthermia, muscle pain.trend of bed sores, increase of serum cpk and creatinine, microcitosi, decrease in haematocrit, increase in alpha-2 globulins, decrease of blood iron.the active substances are: sodium caparsolato and tiacetarsamide sodium.the stage blood blood agent causation is observed on blood smears fixed in methanol and stained with the method may grunwal - giemsa the cultivation of seed is obtained from blood prelevator perfect asepsis insemenzando paddles columbia + 5% of the blood of sheep, put to incubate for two days.small colonies are grey pearl similar to those of mycoplasma with a central point detected.
机译:静脉内给药的药物Caparsolate和Filaramide的量为每天接受治疗的受试者体重0.1 ml / kg,为期两天。导致该疾病的临床治愈(慢性疲劳综合症)确定了以下症状:食欲不振,乏力,乏力,体重减轻,体温过高,肌肉疼痛。褥疮趋势,血清cpk和肌酐增加,微环孢素,血细胞比容降低,α-2球蛋白升高,血铁降低。活性物质为:钠caparsolato和tiacetarsamide钠。在固定于甲醇的血液涂片上观察到阶段性血液药剂的起因,并用该方法染色可能会引起皱纹-giemsa的种子的种植是从血液升压器中获得的最佳无菌无菌insemenzando桨哥伦比亚+ 5%的羊血孵化两天。小菌落是灰色的珍珠,类似于支原体,检测到中心点。

著录项

  • 公开/公告号IT1280014B1

    专利类型

  • 公开/公告日1997-12-23

    原文格式PDF

  • 申请/专利权人 TARELLO WALTER;

    申请/专利号IT1993TO00179

  • 发明设计人 TARELLO WALTER;SATURNINO CARMELA;

    申请日1993-03-17

  • 分类号

  • 国家 IT

  • 入库时间 2022-08-22 02:55:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号